Filing Flows › TherapeuticsMD (TXMD) › Q2 2026 › vs Q1 2026
TherapeuticsMD (TXMD) Q2 2026 vs Q1 2026 (quarter over quarter)
TherapeuticsMD's revenue rose $145K (+20%) from $724K in Q1 2026 to $869K in Q2 2026.
TherapeuticsMD, Q2 2026: revenue $869K (-9% year over year), operating margin -93.9%, net earnings $155K, operating cash flow $779K. The chart draws each line against Q1 2026, the increases inside each band.
Every line
| Line | Q2 2026 | Q1 2026 | Change | % |
|---|---|---|---|---|
| Revenue | $869K | $724K | $145K | +20% |
| Other income, net | $980K | $826K | $154K | +19% |
| Costs & expenses | $1.8M | $1.6M | $299K | +19% |
| Operating costs | $1.7M | $1.4M | $238K | +16% |
| Income tax | $9K | $8K | $1K | +12% |
| Net earnings | $155K | $95K | $60K | +63% |
| General & admin | $1.6M | $1.4M | $224K | +17% |
| Other operating costs | $108K | $94K | $14K | +15% |
| Operating cash sources | $779K | $944K | −$165K | -17% |
| Depreciation & amortization | $95K | $94K | $1K | +1% |
| Share-based compensation | $4K | $2K | $2K | +100% |
| Working capital & other | $525K | $753K | −$228K | -30% |
| Operating cash flow | $779K | $944K | −$165K | -17% |
Questions
How much did TherapeuticsMD's revenue grow quarter over quarter in Q2 2026?
TherapeuticsMD's revenue rose $145K (+20%) from $724K in Q1 2026 to $869K in Q2 2026.